Teladoc Health Inc
NYSE:TDOC
Teladoc Health Inc
NYSE:TDOC
Price:
13.01 USD
-2.4%
Market Closed
Updated:
Apr 28, 2024
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
5.6
Current
5.6
Median
12.5
Industry
Higher
than median
Lower
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=5.6
Enterprise Value
/
2.6B
EBITDA
468.5m
All Countries
| Market Cap | EV/EBITDA | ||||
|---|---|---|---|---|---|
| US |
|
Teladoc Health Inc
NYSE:TDOC
|
2.2B USD | 5.6 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
32.4B USD | 61.4 | |
| US |
|
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 19.6 | |
| US |
|
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 16.5 | |
| JP |
|
M3 Inc
TSE:2413
|
1.3T JPY | 14.6 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
11.4B AUD | 112.7 | |
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
7B USD | -175.3 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.4B USD | 21.5 | |
| SE |
|
Sectra AB
STO:SECT B
|
42.7B SEK | -66.2 | |
| US |
|
Evolent Health Inc
NYSE:EVH
|
3.1B USD | 26.1 | |
| US |
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
2.8B USD | 34.1 |
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
7.1
2-Years Forward
EV/EBITDA
6.2
3-Years Forward
EV/EBITDA
5.7
You don't have any saved screeners yet
